William Rice, Ph.D., has been appointed chief executive officer and chairman at Lorus Therapeutics Inc. Dr. Rice will guide the company’s strategic and clinical missions for targeting essential apoptosis pathways for new cancer therapies.   Dr. Rice most recently served as president, chief executive officer and chairman of the board at Cylene Pharmaceuticals, where he led the strategic and financing activities to design and develop small molecule therapeutics to exploit CK2-driven pathways and n...